BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33327280)

  • 1. Prognostic value of the systemic inflammation response index in human malignancy: A meta-analysis.
    Wei L; Xie H; Yan P
    Medicine (Baltimore); 2020 Dec; 99(50):e23486. PubMed ID: 33327280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of the Prognostic Value of Pretreatment Systemic Inflammation Response Index in Cancer Patients: A Pooled Analysis of 19 Cohort Studies.
    Zhang Y; Liu F; Wang Y
    Dis Markers; 2020; 2020():8854267. PubMed ID: 32934755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and clinicopathological value of systemic inflammation response index (SIRI) in patients with breast cancer: a meta-analysis.
    Zhang S; Cheng T
    Ann Med; 2024 Dec; 56(1):2337729. PubMed ID: 38569199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Inflammation Response Index as a Prognostic Marker in Cancer Patients: A Systematic Review and Meta-Analysis of 38 Cohorts.
    Zhou Q; Su S; You W; Wang T; Ren T; Zhu L
    Dose Response; 2021; 19(4):15593258211064744. PubMed ID: 34987341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and clinicopathological significance of systemic inflammation response index in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhang S; Tang Z
    Front Immunol; 2024; 15():1291840. PubMed ID: 38469315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of the advanced lung cancer inflammation index in patients with gastrointestinal malignancy.
    Zhang L; Zhao K; Kuang T; Wang K; Chai D; Qiu Z; Liu R; Deng W; Wang W
    BMC Cancer; 2023 Jan; 23(1):101. PubMed ID: 36717809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
    Qi F; Xu Y; Zheng Y; Li X; Gao Y
    Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator.
    Chen L; Chen Y; Zhang L; Xue Y; Zhang S; Li X; Song H
    Pathol Oncol Res; 2021; 27():1609811. PubMed ID: 34712105
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection.
    Li S; Lan X; Gao H; Li Z; Chen L; Wang W; Song S; Wang Y; Li C; Zhang H; Xue Y
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2455-2468. PubMed ID: 28828692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of the systemic inflammation response index in gastrointestinal malignancy patients: a pooled analysis of 10,091 participants.
    Liang XW; Liu B; Yu HJ; Chen JC; Cao Z; Wang SZ; Wu JC
    Future Oncol; 2023 Sep; 19(29):1961-1972. PubMed ID: 37800335
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy.
    Qi Q; Zhuang L; Shen Y; Geng Y; Yu S; Chen H; Liu L; Meng Z; Wang P; Chen Z
    Cancer; 2016 Jul; 122(14):2158-67. PubMed ID: 27152949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of systemic immune-inflammation index in surgical esophageal cancer patients: An updated meta-analysis.
    Li X; Zhang S; Lu J; Li C; Li N
    Front Surg; 2022; 9():922595. PubMed ID: 36090319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of the red cell distribution width in esophageal cancer patients: A systematic review and meta-analysis.
    Xu WY; Yang XB; Wang WQ; Bai Y; Long JY; Lin JZ; Xiong JP; Zheng YC; He XD; Zhao HT; Sang XT
    World J Gastroenterol; 2018 May; 24(19):2120-2129. PubMed ID: 29785080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
    Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
    BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of systemic immune-inflammation index in patients with pancreatic cancer: a meta-analysis.
    Li M; Li Z; Wang Z; Yue C; Hu W; Lu H
    Clin Exp Med; 2022 Nov; 22(4):637-646. PubMed ID: 35022918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis.
    Zhang Y; Yang X
    Dis Markers; 2018; 2018():1034037. PubMed ID: 30510601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis.
    Zhao X; Lu H; Sun Y; Liu L; Wang H
    Medicine (Baltimore); 2020 Oct; 99(42):e22804. PubMed ID: 33080755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of tumor length in esophageal Cancer: a systematic review and Meta-analysis.
    Wang ZY; Jiang YZ; Xiao W; Xue XB; Zhang XW; Zhang L
    BMC Cancer; 2021 Sep; 21(1):988. PubMed ID: 34479538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
    Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
    Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis.
    Sun S; Dong H; Yan T; Li J; Liu B; Shao P; Li J; Liang C
    BMC Med Genet; 2020 Jun; 21(1):139. PubMed ID: 32600280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.